Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Lanctôt K AND (cost[Title] OR benefit[Title] OR outcomes[Title] OR pharmacoeconomics[Title]):

Adherence and outcomes: a systematic review of palivizumab utilization. Wong SK et al. Expert Rev Respir Med. (2018)

Cognitive Outcomes following Transcatheter Aortic Valve Implantation: A Systematic Review. Lai KS et al. Cardiovasc Psychiatry Neurol. (2015)

Palivizumab Adherence and Outcomes in Canadian Aboriginal Children. Hui C et al. Pediatr Infect Dis J. (2016)

Search results

Items: 1 to 20 of 25

1.

Plasma Sphingolipids Mediate a Relationship Between Type 2 Diabetes and Memory Outcomes in Patients with Coronary Artery Disease Undertaking Exercise.

Eakin KA, Saleem M, Herrmann N, Cogo-Moreira H, Mielke MM, Oh PI, Haughey NJ, Venkata SLV, Lanctôt KL, Swardfager W.

J Alzheimers Dis. 2019 Apr 17. doi: 10.3233/JAD-181203. [Epub ahead of print]

PMID:
31006687
2.

Screening for Post-Stroke Depression and Cognitive Impairment at Baseline Predicts Long-Term Patient-Centered Outcomes After Stroke.

Kapoor A, Lanctot KL, Bayley M, Herrmann N, Murray BJ, Swartz RH.

J Geriatr Psychiatry Neurol. 2019 Jan;32(1):40-48. doi: 10.1177/0891988718819859.

PMID:
30793663
3.

Lithium Carbonate in a Poststroke Population: Exploratory Analyses of Neuroanatomical and Cognitive Outcomes.

Sun YR, Herrmann N, Scott CJM, Black SE, Swartz RH, Hopyan J, Lanctôt KL.

J Clin Psychopharmacol. 2019 Jan/Feb;39(1):67-71. doi: 10.1097/JCP.0000000000000981.

4.

Cognitive Outcomes After Transcatheter Aortic Valve Implantation: A Metaanalysis.

Khan MM, Herrmann N, Gallagher D, Gandell D, Fremes SE, Wijeysundera HC, Radhakrishnan S, Sun YR, Lanctôt KL.

J Am Geriatr Soc. 2018 Feb;66(2):254-262. doi: 10.1111/jgs.15123. Epub 2017 Nov 21.

PMID:
29159840
5.

Adherence and outcomes: a systematic review of palivizumab utilization.

Wong SK, Li A, Lanctôt KL, Paes B.

Expert Rev Respir Med. 2018 Jan;12(1):27-42. doi: 10.1080/17476348.2018.1401926. Epub 2017 Nov 13. Review.

PMID:
29130355
6.

Palivizumab Adherence and Outcomes in Canadian Aboriginal Children.

Hui C, Paes B, Papenburg J, Mitchell I, Li A, Lanctôt KL; CARESS Investigators.

Pediatr Infect Dis J. 2016 Nov;35(11):1187-1193.

PMID:
27331856
7.

Outcomes of Infants Receiving Palivizumab Prophylaxis for Respiratory Syncytial Virus in Canada and Italy: An International, Prospective Cohort Study.

Manzoni P, Paes B, Lanctôt KL, Dall'Agnola A, Mitchell I, Calabrese S, Maule M, Girardi E, Harimoto T, Li A.

Pediatr Infect Dis J. 2017 Jan;36(1):2-8.

PMID:
27649365
8.

Risk Factors for Progression of Alzheimer Disease in a Canadian Population: The Canadian Outcomes Study in Dementia (COSID).

Herrmann N, Harimoto T, Balshaw R, Lanctôt KL; Canadian Outcomes Study in Dementia (COSID) Investigators.

Can J Psychiatry. 2015 Apr;60(4):189-99.

9.

Cognitive Outcomes following Transcatheter Aortic Valve Implantation: A Systematic Review.

Lai KS, Herrmann N, Saleem M, Lanctôt KL.

Cardiovasc Psychiatry Neurol. 2015;2015:209569. doi: 10.1155/2015/209569. Epub 2015 Feb 15. Review.

10.

Cost-effectiveness of respiratory syncytial virus prophylaxis in premature infants less than 32 weeks gestational age in Turkey.

Paes B, Lanctôt K.

Turk J Pediatr. 2013 Sep-Oct;55(5):564-7. No abstract available.

PMID:
24382545
11.

A review of cost-effectiveness of palivizumab for respiratory syncytial virus.

Hussman JM, Li A, Paes B, Lanctôt KL.

Expert Rev Pharmacoecon Outcomes Res. 2012 Oct;12(5):553-67. doi: 10.1586/erp.12.45. Epub 2012 Nov 11. Review.

PMID:
23140255
12.

The cost effectiveness of palivizumab in congenital heart disease: a review of the current evidence.

Hussman JM, Lanctôt KL, Paes B.

J Med Econ. 2013;16(1):115-24. doi: 10.3111/13696998.2012.734886. Epub 2012 Oct 10. Review.

PMID:
23016567
13.

Validity and responsiveness to change of clinically derived MDS scales in Alzheimer disease outcomes research.

Smart KA, Herrmann N, Lanctôt KL.

J Geriatr Psychiatry Neurol. 2011 Jun;24(2):67-72. doi: 10.1177/0891988711402347. Epub 2011 Apr 1.

PMID:
21460341
14.

Major depressive disorder predicts completion, adherence, and outcomes in cardiac rehabilitation: a prospective cohort study of 195 patients with coronary artery disease.

Swardfager W, Herrmann N, Marzolini S, Saleem M, Farber SB, Kiss A, Oh PI, Lanctôt KL.

J Clin Psychiatry. 2011 Sep;72(9):1181-8. doi: 10.4088/JCP.09m05810blu. Epub 2010 Nov 2.

PMID:
21208573
15.

The relation between disease severity and cost of caring for patients with Alzheimer disease in Canada.

Herrmann N, Tam DY, Balshaw R, Sambrook R, Lesnikova N, Lanctôt KL; Canadian Outcomes Study in Dementia (COSID) Investigators.

Can J Psychiatry. 2010 Dec;55(12):768-75.

PMID:
21172097
16.

The pharmacoeconomics of cognitive enhancers in moderate to severe Alzheimer's disease.

Cappell J, Herrmann N, Cornish S, Lanctôt KL.

CNS Drugs. 2010 Nov;24(11):909-27. doi: 10.2165/11539530-000000000-00000. Review.

PMID:
20932064
17.

The cost effectiveness of palivizumab: a systematic review of the evidence.

Smart KA, Lanctôt KL, Paes BA.

J Med Econ. 2010;13(3):453-63. doi: 10.3111/13696998.2010.499749. Review.

PMID:
20653398
18.

The cost effectiveness of palivizumab in term Inuit infants in the Eastern Canadian Arctic.

Tam DY, Banerji A, Paes BA, Hui C, Tarride JE, Lanctôt KL.

J Med Econ. 2009;12(4):361-70. doi: 10.3111/13696990903442155.

PMID:
19900071
19.

Comparison of the cost of hospitalization for respiratory syncytial virus disease versus palivizumab prophylaxis in Canadian Inuit infants.

Banerji A, Lanctôt KL, Paes BA, Masoud ST, Tam DY, Macdonald WA, Roberts A.

Pediatr Infect Dis J. 2009 Aug;28(8):702-6. doi: 10.1097/INF.0b013e31819df78e.

PMID:
19461555
20.

The cost-effectiveness of palivizumab for respiratory syncytial virus prophylaxis in premature infants with a gestational age of 32-35 weeks: a Canadian-based analysis .

Lanctôt KL, Masoud ST, Paes BA, Tarride JE, Chiu A, Hui C, Francis PL, Oh PI.

Curr Med Res Opin. 2008 Nov;24(11):3223-37. doi: 10.1185/03007990802484234 . Epub 2008 Oct 16.

PMID:
18928643

Supplemental Content

Loading ...
Support Center